Do We Know the Minimal Clinically Important Difference (MCID) for COPD Exacerbations?

ISSN： 1541-2555

Source： COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol.10, Iss.2, 2013-03, pp. : 243-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Omega 3: Where Do We Stand?

By Versari Daniele Daghini Elena Salvetti Guido Salvetti Antonio

High Blood Pressure & Cardiovascular Prevention, Vol. 15, Iss. 4, 2008-01 ,pp. : 225-230

Adis International

Access to resources Recommend Favorite

Validity of Minimal Clinically Important Difference Values for the Multiple Sclerosis Walking Scale-12?

European Neurology, Vol. 71, Iss. 3-4, 2014-01 ,pp. : 196-202

Karger

Access to resources Recommend Favorite

Angiotensin Receptor Blockers: When Do We Prescribe Them in Patients with Diabetes Mellitus?

By Ruilope M.

High Blood Pressure & Cardiovascular Prevention, Vol. 10, Iss. 1, 2003-01 ,pp. : 47-49

Adis International

Access to resources Recommend Favorite

Do we need assessment of nonpulmonary vein triggers for successful ablation of atrial fibrillation?

By Wichterle Dan

Future Cardiology, Vol. 9, Iss. 4, 2013-07 ,pp. : 471-474

Future Medicine

Access to resources Recommend Favorite

Is the Primary Mechanism Underlying COPD: Inflammation or Ischaemia?

By Pearson Michael

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 10, Iss. 4, 2013-08 ,pp. : 536-541

Informa Healthcare

Access to resources Recommend Favorite